FDA grants Priority Review to flibanserin for treating postmenopausal HSDD

https://www.contemporaryobgyn.net/view/fda-grants-priority-review-to-flibanserin-for-treating-postmenopausal-hsdd

Previous
Previous

FDA Grants Fast Track Designation for Sprout's Flibanserin to Treat HSDD in Postmenopausal Women

Next
Next

She Wears Bright Pink And Fights For Women’s Pleasure. Now, The Medical World Is Listening.